gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
- Author
- SCHWARTZENTRUBER, Douglas J1 ; LAWSON, David H2 ; KENDRA, Kari L10 ; WHITE, Richard L11 ; GONZALEZ, Rene12 ; KUZEL, Timothy M13 ; CURTI, Brendan14 ; LEMING, Phillip D15 ; WHITMAN, Eric D16 ; BALKISSOON, Jai17 ; REINTGEN, Douglas S18 ; KAUFMAN, Howard19 ; RICHARDS, Jon M; MARINCOLA, Francesco M20 ; MERINO, Maria J21 ; ROSENBERG, Steven A22 ; CHOYKE, Peter23 ; VENA, Don24 ; HWU, Patrick; CONRY, Robert M3 ; MILLER, Donald M4 ; TREISMAN, Jonathan5 ; GAILANI, Fawaz6 ; RILEY, Lee7 ; CONLON, Kevin8 ; POCKAJ, Barbara9
[1] Indiana University Health Goshen Center for Cancer Care, Goshen, IN, United States
[2] Winship Cancer Institute, Emory University, Atlanta, United States
[3] University of Alabama Health Services Foundation Comprehensive Cancer Center, Birmingham, United States
[4] James Graham Brown Cancer Center, Louisville, KY, United States
[5] St. Luke's Medical Center, Milwaukee, United States
[6] Kaiser Permanente Medical Center, Riverside, United States
[7] Summit Medical Center, Oakland California, United States
[8] St. Luke's Hospital, Bethlehem, PA, United States
[9] Department of Surgical Pathology, National Institutes of Health, Bethesda, MD, United States
[10] Surgery Branch, National Institutes of Health, Bethesda, MD, United States
[11] Cancer Therapy Evaluation Program, National Institutes of Health, Bethesda, MD, United States
[12] National Cancer Institute, National Institutes of Health, Bethesda, MD, United States
[13] Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology, National Institutes of Health, Bethesda, MD, United States
[14] EMMES Corp., Rockville, MD, United States
[15] Mayo Clinic, Phoenix, AZ, United States
[16] Ohio State University, Columbus, United States
[17] Carolinas Medical Center, Charlotte, NC, United States
[18] University of Colorado Denver, Denver, United States
[19] Northwestern University, United States
[20] Rush University Medical Center, Chicago, United States
[21] Earle A. Chiles Research Institute, Portland, OR, United States
[22] Christ Hospital, Cincinnati, United States
[23] Atlantic Melanoma Center, Morristown, NJ, United States
[24] University of South Florida, Tampa, United States - Source
The New England journal of medicine. 2011, Vol 364, Num 22, pp 2119-2127, 9 p ; ref : 15 ref
- CODEN
- NEJMAG
- ISSN
- 0028-4793
- Scientific domain
- General medicine general surgery
- Publisher
- Massachusetts Medical Society, Waltham, MA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Homme Interleukine 2 Malade Médecine Mélanome malin Peptide Stade avancé Vaccin Vaccination Antigène gp100 Cancer Cytokine Tumeur maligne
- Keyword (en)
- Human Interleukin 2 Patient Medicine Malignant melanoma Peptides Advanced stage Vaccine Vaccination Cancer Cytokine Malignant tumor
- Keyword (es)
- Hombre Interleuquina 2 Enfermo Medicina Melanoma maligno Péptido Estadio avanzado Vacuna Vacunación Cáncer Citoquina Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B08 Dermatology / 002B08A Tumors of the skin and soft tissue. Premalignant lesions
- Discipline
- Dermatology Generalities in medical sciences
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 24199447
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1056/NEJMoa1012863 
https://dx.doi.org/10.1056/NEJMoa1012863
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1012863\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:74:\"gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:3:\"364\";s:8:\"\u0000*\u0000issue\";s:2:\"22\";s:8:\"\u0000*\u0000spage\";s:4:\"2119\";s:8:\"\u0000*\u0000epage\";s:4:\"2127\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:16:\"SCHWARTZENTRUBER\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Douglas J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:25:{i:0;s:15:\"LAWSON, David H\";i:1;s:14:\"KENDRA, Kari L\";i:2;s:16:\"WHITE, Richard L\";i:3;s:14:\"GONZALEZ, Rene\";i:4;s:16:\"KUZEL, Timothy M\";i:5;s:14:\"CURTI, Brendan\";i:6;s:17:\"LEMING, Phillip D\";i:7;s:15:\"WHITMAN, Eric D\";i:8;s:15:\"BALKISSOON, Jai\";i:9;s:19:\"REINTGEN, Douglas S\";i:10;s:15:\"KAUFMAN, Howard\";i:11;s:15:\"RICHARDS, Jon M\";i:12;s:22:\"MARINCOLA, Francesco M\";i:13;s:15:\"MERINO, Maria J\";i:14;s:19:\"ROSENBERG, Steven A\";i:15;s:13:\"CHOYKE, Peter\";i:16;s:9:\"VENA, Don\";i:17;s:12:\"HWU, Patrick\";i:18;s:15:\"CONRY, Robert M\";i:19;s:16:\"MILLER, Donald M\";i:20;s:18:\"TREISMAN, Jonathan\";i:21;s:14:\"GAILANI, Fawaz\";i:22;s:10:\"RILEY, Lee\";i:23;s:13:\"CONLON, Kevin\";i:24;s:15:\"POCKAJ, Barbara\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:74:\"gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1012863\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:74:\"gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:3:\"364\";s:8:\"\u0000*\u0000issue\";s:2:\"22\";s:8:\"\u0000*\u0000spage\";s:4:\"2119\";s:8:\"\u0000*\u0000epage\";s:4:\"2127\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:16:\"SCHWARTZENTRUBER\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Douglas J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:25:{i:0;s:15:\"LAWSON, David H\";i:1;s:14:\"KENDRA, Kari L\";i:2;s:16:\"WHITE, Richard L\";i:3;s:14:\"GONZALEZ, Rene\";i:4;s:16:\"KUZEL, Timothy M\";i:5;s:14:\"CURTI, Brendan\";i:6;s:17:\"LEMING, Phillip D\";i:7;s:15:\"WHITMAN, Eric D\";i:8;s:15:\"BALKISSOON, Jai\";i:9;s:19:\"REINTGEN, Douglas S\";i:10;s:15:\"KAUFMAN, Howard\";i:11;s:15:\"RICHARDS, Jon M\";i:12;s:22:\"MARINCOLA, Francesco M\";i:13;s:15:\"MERINO, Maria J\";i:14;s:19:\"ROSENBERG, Steven A\";i:15;s:13:\"CHOYKE, Peter\";i:16;s:9:\"VENA, Don\";i:17;s:12:\"HWU, Patrick\";i:18;s:15:\"CONRY, Robert M\";i:19;s:16:\"MILLER, Donald M\";i:20;s:18:\"TREISMAN, Jonathan\";i:21;s:14:\"GAILANI, Fawaz\";i:22;s:10:\"RILEY, Lee\";i:23;s:13:\"CONLON, Kevin\";i:24;s:15:\"POCKAJ, Barbara\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:74:\"gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1012863\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1012863\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:74:\"gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:3:\"364\";s:8:\"\u0000*\u0000issue\";s:2:\"22\";s:8:\"\u0000*\u0000spage\";s:4:\"2119\";s:8:\"\u0000*\u0000epage\";s:4:\"2127\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:16:\"SCHWARTZENTRUBER\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Douglas J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:25:{i:0;s:15:\"LAWSON, David H\";i:1;s:14:\"KENDRA, Kari L\";i:2;s:16:\"WHITE, Richard L\";i:3;s:14:\"GONZALEZ, Rene\";i:4;s:16:\"KUZEL, Timothy M\";i:5;s:14:\"CURTI, Brendan\";i:6;s:17:\"LEMING, Phillip D\";i:7;s:15:\"WHITMAN, Eric D\";i:8;s:15:\"BALKISSOON, Jai\";i:9;s:19:\"REINTGEN, Douglas S\";i:10;s:15:\"KAUFMAN, Howard\";i:11;s:15:\"RICHARDS, Jon M\";i:12;s:22:\"MARINCOLA, Francesco M\";i:13;s:15:\"MERINO, Maria J\";i:14;s:19:\"ROSENBERG, Steven A\";i:15;s:13:\"CHOYKE, Peter\";i:16;s:9:\"VENA, Don\";i:17;s:12:\"HWU, Patrick\";i:18;s:15:\"CONRY, Robert M\";i:19;s:16:\"MILLER, Donald M\";i:20;s:18:\"TREISMAN, Jonathan\";i:21;s:14:\"GAILANI, Fawaz\";i:22;s:10:\"RILEY, Lee\";i:23;s:13:\"CONLON, Kevin\";i:24;s:15:\"POCKAJ, Barbara\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:74:\"gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa1012863\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:74:\"gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:3:\"364\";s:8:\"\u0000*\u0000issue\";s:2:\"22\";s:8:\"\u0000*\u0000spage\";s:4:\"2119\";s:8:\"\u0000*\u0000epage\";s:4:\"2127\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:16:\"SCHWARTZENTRUBER\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Douglas J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:25:{i:0;s:15:\"LAWSON, David H\";i:1;s:14:\"KENDRA, Kari L\";i:2;s:16:\"WHITE, Richard L\";i:3;s:14:\"GONZALEZ, Rene\";i:4;s:16:\"KUZEL, Timothy M\";i:5;s:14:\"CURTI, Brendan\";i:6;s:17:\"LEMING, Phillip D\";i:7;s:15:\"WHITMAN, Eric D\";i:8;s:15:\"BALKISSOON, Jai\";i:9;s:19:\"REINTGEN, Douglas S\";i:10;s:15:\"KAUFMAN, Howard\";i:11;s:15:\"RICHARDS, Jon M\";i:12;s:22:\"MARINCOLA, Francesco M\";i:13;s:15:\"MERINO, Maria J\";i:14;s:19:\"ROSENBERG, Steven A\";i:15;s:13:\"CHOYKE, Peter\";i:16;s:9:\"VENA, Don\";i:17;s:12:\"HWU, Patrick\";i:18;s:15:\"CONRY, Robert M\";i:19;s:16:\"MILLER, Donald M\";i:20;s:18:\"TREISMAN, Jonathan\";i:21;s:14:\"GAILANI, Fawaz\";i:22;s:10:\"RILEY, Lee\";i:23;s:13:\"CONLON, Kevin\";i:24;s:15:\"POCKAJ, Barbara\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:74:\"gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
